Vetter

Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards

Retrieved on: 
Tuesday, March 26, 2024
Packaging, Medical Supplies, Health, Manufacturing, General Health, Pharmaceutical, Biotechnology, Patient, Multimedia, Conference, Growth, Vetter

Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.

Key Points: 
  • Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.
  • View the full release here: https://www.businesswire.com/news/home/20240326776450/en/
    The Vetter team including Managing Director Peter Soelkner (2nd from left) is proud to accept the CDMO Leadership Awards 2024 on behalf of the company.
  • (Photo: Business Wire)
    “We are dedicated to embodying the characteristics that this award highlights to provide the best to our customers and their patients.
  • Those best at serving their customers and thus patients are recognized as the 2024 CDMO Leadership Award winners.”

Vetter looks ahead to further expansions to meet supply chain demand

Retrieved on: 
Tuesday, October 17, 2023
Professional Services, Pharmaceutical, Commercial Building & Real Estate, Construction & Property, Data Analytics, Packaging, Science, Biotechnology, Transport, Health, Logistics, Supply Chain Management, Other Science, Manufacturing, Patient, Investment, Multimedia, CDMO, Growth, Fine chemical, Vetter, EU

Vetter , a leading global Contract Development and Manufacturing Organization (CDMO), announces additional investments as part of its long-term dedication to customer partnerships.

Key Points: 
  • Vetter , a leading global Contract Development and Manufacturing Organization (CDMO), announces additional investments as part of its long-term dedication to customer partnerships.
  • Vetter’s extensive 40+ years of experience in aseptic filling and packaging shows a consistent desire for sustainable growth and corporate development.
  • The pharmaceutical service provider plans with future-driven considerations to meet its long-lead goals for continued expansion and customer satisfaction.
  • “In our industry, the needs of our customers and the patients they serve continue to evolve,” emphasizes Vetter Managing Director Peter Soelkner.

Vetter Performs Extraordinarily with Six Wins in the 12th Annual CDMO Leadership Awards

Retrieved on: 
Tuesday, March 28, 2023
Biotechnology, Health, Science, Pharmaceutical, Research, Senior, Cooperative Development Services, Organization, Multimedia, CDMO, Patient, Conference, Republican Conference Chair, Management, Nursing, Vetter

Vetter , a globally operating Contract Development and Manufacturing Organization (CDMO), earned the esteemed 2023 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service.

Key Points: 
  • Vetter , a globally operating Contract Development and Manufacturing Organization (CDMO), earned the esteemed 2023 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service.
  • In addition, the company was awarded Champion Status for quality, expertise and compatibility – both recognitions for the second year in a row.
  • In its 12th year, now dubbed the CDMO Leadership Awards (formally, CMO Leadership Awards) and thus including the important clinical development support companies such as Vetter are offering, these prestigious honors were presented by Outsourced Pharma and supported by Life Science Leader.
  • View the full release here: https://www.businesswire.com/news/home/20230328005664/en/
    The Vetter team is proud to accept the CDMO Leadership Awards.

Vetter Strengthens Worldwide Commitment to Sustainable Business Practices

Retrieved on: 
Wednesday, March 8, 2023
Packaging, Medical Supplies, Health, Manufacturing, Pharmaceutical, Biotechnology, United Nations Global Compact, COP, CDMO, Communication, CO2, Multimedia, Corruption, UN, Progress, Vetter, Organization, Technical Service Council, Senior, Renewable energy

The globally operating Contract Development and Manufacturing Organization (CDMO) is one of the pioneers in the industry regarding responsible, sustainable, and transparent business practices.

Key Points: 
  • The globally operating Contract Development and Manufacturing Organization (CDMO) is one of the pioneers in the industry regarding responsible, sustainable, and transparent business practices.
  • Henryk Badack, Senior Vice President Technical Service and Internal Project Management is responsible for all global sustainability activities at Vetter.
  • With its own comprehensive initiatives, Vetter also simultaneously supports its customers and partners in their sustainable supply chain.
  • Launched in 2000, the UN Global Compact is the largest corporate initiative on sustainable business worldwide.

Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market

Retrieved on: 
Wednesday, February 1, 2023
Health, Pharmaceutical, II, Therapy, Investment, Supply chain management, Marketing, Drug development, Vetter, Senior, Failure, Multimedia, CDMO, Pharmaceutical industry, Fine chemical

A testament to this commitment is evidenced by the success of its Skokie facility which has already contributed to bring five new customer products to market since it began full operations in 2011, with another four expected to launch in the next months.

Key Points: 
  • A testament to this commitment is evidenced by the success of its Skokie facility which has already contributed to bring five new customer products to market since it began full operations in 2011, with another four expected to launch in the next months.
  • Currently, Vetter Development Service runs more than 80 projects in phase I and II clinical development.
  • In the past years, the facility executed over 30 transfers from its early clinical projects to Germany for further late-stage development.
  • Since its opening the site’s performance has proven exceptional with fourteen projects already won and more in the pipeline.

Strength in Sustainability: Vetter Wins Gold in EcoVadis Ranking

Retrieved on: 
Wednesday, January 18, 2023
Manufacturing, Environment, Health, Pharmaceutical, Packaging, Global Reporting Initiative, Labour, Sustainable procurement, United Nations Global Compact, CSR, Patient, ISO, Ethics, CDMO, Human rights, Multimedia, Sustainability, Risk management, Vetter

Vetter , a globally leading contract development and manufacturing organization (CDMO), achieved gold status in the renowned, independent EcoVadis sustainability ranking.

Key Points: 
  • Vetter , a globally leading contract development and manufacturing organization (CDMO), achieved gold status in the renowned, independent EcoVadis sustainability ranking.
  • View the full release here: https://www.businesswire.com/news/home/20230118005737/en/
    Vetter achieves gold status in the EcoVadis sustainability ranking and is now among the top five percent of the industry.
  • (Graphic: Business Wire)
    Sustainability plays an important role at Vetter and has been deeply rooted in its corporate strategy for many years.
  • “Tens of thousands of companies around the world, including many of our customers, use EcoVadis as an indicator of sustainable business practices.

Vetter-Hackathon 2022: Innovation Booster Through Employee Participation

Retrieved on: 
Tuesday, November 29, 2022
Technology, Professional Services, Medical Supplies, Clinical Trials, Biotechnology, Other Manufacturing, Health, Health Technology, Packaging, Other Technology, Manufacturing, Software, Other Professional Services, Mobile, Wireless, Human Resources, Pharmaceutical, Data Management, Particular, Weakness, Multimedia, Patient safety, Syringe, Orangi Pilot Project, Thought, Senior, Pharmacy, Vetter, Failure, CDMO, Suggestion, Management, Hackathon

To drive this strategy forward, also new collaborative formats are constantly being created, such as the Vetter Hackathon.

Key Points: 
  • To drive this strategy forward, also new collaborative formats are constantly being created, such as the Vetter Hackathon.
  • View the full release here: https://www.businesswire.com/news/home/20221129005760/en/
    Using creative thinking to move ideas forward: The project teams discuss their approaches.
  • (Photo: Business Wire)
    "The great interest and strong desire of our employees is to help make Vetter an even better company.
  • With this innovative format, we deliberately give our employees time to engage with their ideas," says Vetter Managing Director Peter Soelkner.

New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure

Retrieved on: 
Thursday, October 27, 2022
Packaging, Health, Other Construction & Property, Manufacturing, Construction & Property, Pharmaceutical, Biotechnology, Biotechnology, Growth, Quality control, Senior, CDMO, Investment, Compliance, Syringe, Social responsibility, Multimedia, Temperature, Face, Laboratory, Warehouse, Vetter

20 million euros, the new fully automated building provides storage space for materials with high-stock turnover rates such as packaging components and thus optimizing the companys logistical infrastructure .

Key Points: 
  • 20 million euros, the new fully automated building provides storage space for materials with high-stock turnover rates such as packaging components and thus optimizing the companys logistical infrastructure .
  • View the full release here: https://www.businesswire.com/news/home/20221027005723/en/
    New fully automated Vetter warehouse for packaging materials.
  • (Photo: Business Wire)
    Construction of the warehouse began in April 2021 and was designed to further address the companys strategic expansion plans.
  • Vetter Pharma International GmbH: New fully automated Vetter warehouse for packaging materials.

MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH

Retrieved on: 
Tuesday, July 26, 2022
Antibody, Supply chain management, Inflammation, 40, Veni, vidi, vici, Tissue, U.S. Securities and Exchange Commission, Forward-looking statement, Temperature, Moonlake, Psoriatic arthritis, Research, Chemokine, Vetter, Private Securities Litigation Reform Act, Severity, Marketing, VHH, KDA, Good manufacturing practice, Senior, Security (finance), Patient, Nasdaq, Single-domain antibody, Syringe, Good, Hidradenitis suppurativa, Pharmaceutical industry, Medical device, Vaccine, Ablynx, Sanofi

ZUG, Switzerland, July 26, 2022 MoonLake Immunotherapeutics AG (MoonLake; Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced that it has signed a Master Development Services Agreement with Vetter Pharma International GmbH (Vetter), a leading global contract development and manufacturing organization for fill and finish services, ranging from development support, including clinical manufacturing, through to commercial supply.

Key Points: 
  • ZUG, Switzerland, July 26, 2022 MoonLake Immunotherapeutics AG (MoonLake; Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced that it has signed a Master Development Services Agreement with Vetter Pharma International GmbH (Vetter), a leading global contract development and manufacturing organization for fill and finish services, ranging from development support, including clinical manufacturing, through to commercial supply.
  • Under the agreement Vetter will be responsible for the aseptic filling of syringes with sonelokimab, and the subsequent assembly into an autoinjector combination device and packaging.
  • Development studies associated with the manufacturing of sub-cutaneous sonelokimab for clinical trials and commercial volumes have been concluded, and technical engineering batches started in Q2 2022.
  • Oliver Daltrop, Chief Technical Officer of MoonLake, said, I am excited to work with such a high quality and reliable partner.

Vetter to Launch Incubator with Two Distinct Launchpads - Transforming Crypto & Raising the Bar in DeFi

Retrieved on: 
Thursday, May 12, 2022
Crypto, TA, Vetter, News, Learning curve, A.I, Vetter Pharma, Research, Industry, Probability, Time, Awareness, Decentralized finance, NFT, Crowdsourcing, Cryptocurrency, Television, Mobile phone, Calendar

and crowdsourcing, designed for crypto users to confidently locate promising new crypto projects getting released to the market for the first time.

Key Points: 
  • and crowdsourcing, designed for crypto users to confidently locate promising new crypto projects getting released to the market for the first time.
  • It helps users discover and sort for hidden gems newly launching across multiple networks.
  • Vetter University - An educational video library curated by the global Vetter community to introduce users to the basics (and beyond) of decentralized finance (DeFi).
  • Major billboards in Rome as well as targeted digital ad placements are also underway to maximize coverage and exposure.